Tang Kevin C's Form 4 filing
Aptevo Therapeutics Inc. (APVO) · filed Nov 26, 2021
- Accession no.
- 0001209191-21-066910
- Filed
- Nov 26, 2021, 1:02 PM ET
- Trade date
- Nov 23, 2021
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions. Open-market sales total $10.4M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tang Kevin CCIK 0001178579 | Other: Exit Filing |
| Tang Capital Partners LPCIK 0001191935 | Other: Exit Filing |
| Tang Capital Management LLCCIK 0001232621 | Other: Exit Filing |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 23, 2021 | Common Stock | SSaleDisposed | −161,336 | $13.52 | −$2,181,520.86 | 760,000 | Indirect | |
| Nov 23, 2021 | Common Stock | SSaleDisposed | −124,509 | $12.45 | −$1,550,186.85 | 635,491 | Indirect | |
| Nov 23, 2021 | Common Stock | SSaleDisposed | −75,491 | $11.74 | −$886,430.42 | 560,000 | Indirect | |
| Nov 23, 2021 | Common Stock | SSaleDisposed | −149,111 | $11.19 | −$1,668,432.8 | 410,889 | Indirect | |
| Nov 23, 2021 | Common Stock | SSaleDisposed | −50,889 | $10.43 | −$530,665.4 | 360,000 | Indirect | |
| Nov 23, 2021 | Common Stock | SSaleDisposed | −200,000 | $10.07 | −$2,014,440 | 160,000 | Indirect | |
| Nov 23, 2021 | Common Stock | SSaleDisposed | −160,000 | $9.60 | −$1,536,560 | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.